Financial data temporarily unavailable. Try again in a few moments.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001304492-26-000046 | Jun 30, 2026 | Aug 11, 2026 | Aug 11, 2026 20:08 UTC | EDGAR |
| 8-K | 0001304492-26-000045 | Aug 11, 2026 | Aug 11, 2026 | Aug 11, 2026 20:05 UTC | EDGAR |
| 8-K | 0001304492-26-000041 | Aug 4, 2026 | Aug 6, 2026 | Aug 6, 2026 20:51 UTC | EDGAR |
| 10-K | 0001304492-26-000027 | Mar 31, 2026 | Jun 25, 2026 | Jun 25, 2026 19:05 UTC | EDGAR |
| 8-K | 0001304492-26-000024 | Jun 10, 2026 | Jun 10, 2026 | Jun 10, 2026 20:45 UTC | EDGAR |
| 8-K | 0001304492-26-000019 | Apr 21, 2026 | Apr 21, 2026 | Apr 21, 2026 11:32 UTC | EDGAR |
| 8-K | 0001304492-26-000016 | Mar 31, 2026 | Apr 6, 2026 | Apr 6, 2026 11:31 UTC | EDGAR |
| 8-K | 0001304492-26-000014 | Mar 25, 2026 | Apr 1, 2026 | Apr 1, 2026 11:30 UTC | EDGAR |
Direct links to SEC EDGAR. ATEX has additional filings available on the SEC site.
6 numbers Anterix Inc. later changed — same XBRL tag, both filings linked.
Net Income (Loss) Attributable to Parent·FY 2024
Major restatementwas-$9.1M
Revised up.
Net Income (Loss) Attributable to Parent·Q3 2017
Major restatementwas-$5.7M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q2 2021
Major restatementwas-$11.9M
Revised up in a 10-Q.
Operating Income (Loss)·Q2 2021
Major restatementwas-$12M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2021
Major restatementwas-$12M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q1 2020
Major restatementwas-$4.6M
Revised down in a 10-Q.
ATEX is not the only one.
See every restatement we've found across the market — or get an alert the next time ATEX revises a number.
Restatements are detected by comparing every vintage of a fact across all of Anterix Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ATEX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Anterix Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ATEX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ATEX and publish the result to your public profile.
Ask about Anterix Inc.
Continue in Workspace — cited answers on ATEX, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs